Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty - A 5-year follow-up of 16 patients

Scandinavian Journal of Surgery

Volumn 99, Issue 1, 2010, Pages 32-37

  Tapaninen, T S ^a,b   Venesmaa, P K ^a   Jurvelin, J S ^b   Miettinen, H J A ^a   Kroger H P J ^a,b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Alendronate; Bisphosphonates; Bone mineral density; Dual X ray absorptiometry; Periprosthetic bone loss; Total hip arthroplasty

Indexed keywords

EID: 77950492845     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/145749691009900108     Document Type: Review

References (30)

1. Kobayashi S, Saito N, Horiuchi H, Iorio R, Takaoka K: Poor bone quality or hip structure as risk factors affecting survival of total-hip arthroplasty. Lancet 2000;355:1499-1504
2. Taylor M, Tanner KE: Fatigue failure of cancellous bone: a possible cause of implant migration and loosening. J Bone Joint Surg Br 1997;779:181-182
3. Bobyn JD, Mortimer ES, Glassman AH et al: Producing and avoiding stress shielding. Laboratory and clinical observations of noncemented total hip arthroplasty. Clin Orthop Relat Res 1992;274:79-96
4. Huiskes R: The various stress patterns of press-fit, ingrown, and cemented femoral stems. Clin Orthop Relat Res 1990; 261:27-38
5. Huiskes R, Weinans H, van Rietbergen B: The relationship between stress shielding and bone resorption around total hip stems and the effects of flexible materials. Clin Orthop Relat Res 1992;274:124-134
6. Sychterz CJ, Engh CA: The influence of clinical factors on periprosthetic bone remodeling. Clin Orthop Relat Res 1995; 322:285-292
7. Kiratli BJ, Checovich MM, McBeath AA, Wilson MA, Heiner JP: Measurement of bone mineral density by dual-energy x-ray absorptiometry in patients with the Wisconsin hip, an uncemented femoral stem. J Arthroplasty 1996;11(2):184-193
8. Kröger H, Miettinen H, Arnala I et al: Evaluation of periprosthetic bone using dual-energy x-ray absorptiometry: precision of the method and effect of operation on bone mineral density. J Bone Miner Res 1996;11(10):1526-1530
9. Marchetti ME, Steinberg GG, Greene JM, Jenis LG, Baran DT: A prospective study of proximal femur bone mass following cemented and uncemented hip arthroplasty. J Bone Miner Res 1996;11(7):1033-1039
10. Nishii T, Sugano N, Masuhara K et al: Longitudinal evaluation of time related bone remodeling after cementless total hip arthroplasty. Clin Orthop Relat Res 1997;339:121-131
11. Trevisan C, Bigoni M, Randelli G et al: Periprosthetic bone density around fully hydroxyapatite coated femoral stem. Clin Orthop Relat Res 1997;340:109-117
12. Wixson RL, Stulberg SD, Van Flandern GJ, Puri L: Maintenance of proximal bone mass with an uncemented femoral stem analysis with dual-energy x-ray absorptiometry. J Arthroplasty 1997;12(4):365-372
13. Kröger H, Venesmaa P, Jurvelin J et al: Bone density at the proximal femur after total hip arthroplasty. Clin Orthop Relat Res 1998;352:66-74 Review
14. Venesmaa PK, Kröger HP, Miettinen HJ et al: Monitoring of periprosthetic BMD after uncemented total hip arthroplasty with dual-energy X-ray absorptiometry a 3-year follow-up study. J Bone Miner Res 2001;16(6):1056-1061
15. Venesmaa PK, Kröger HP, Jurvelin JS et al: Periprosthetic bone loss after cemented total hip arthroplasty: a prospective 5-year dual energy radiographic absorptiometry study of 15 patients. Acta Orthop Scand 2003;74(1):31-36
16. Engh CA, McGovern TF, Bobyn JD, Harris WH: A quantitative evaluation of periprosthetic bone-remodeling after cementless total hip arthroplasty. J Bone Joint Surg Am 1992;74(7):1009-1020
17. Balena R, Toolan BC, Shea M et al: The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. J Clin Invest 1993;92(6): 2577-2586
18. Chesnut CH 3rd, McClung MR, Ensrud KE et al: Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling. Am J Med 1995;99(2):144-152
19. Devogelaer JP, Broll H, Correa-Rotter R et al: Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis. Bone 1996;18(2):141-150
20. Hosking D, Chilvers CE, Christiansen C et al: Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group. N Engl J Med 1998;338(8):485-492
21. Bone HG, Hosking D, Devogelaer JP e al: Alendronate Phase III Osteoporosis Treatment Study Group. Ten years' experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 2004;350(12):1189-1199
22. Papapoulos SE, Quandt SA, Liberman UA, Hochberg MC, Thompson DE: Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women. Osteoporos Int 2005;16(5):468-74. Review
23. Venesmaa PK, Kröger HP, Miettinen HJ et al: Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty: a prospective randomized study. J Bone Miner Res 2001;16(11):2126-2131
24. Arabmotlagh M, Rittmeister M, Hennigs T: Alendronate prevents femoral periprosthetic bone loss following total hip arthroplasty: prospective randomized double-blind study. J Orthop Res 2006;24(7):1336-1341
25. Shetty N, Hamer A J, Stockley I, Eastell R, Willkinson JM: Clinical and radiological outcome of total hip replacement five years after pamidronate therapy J Bone Joint Surg Br 2006; 88(10):1309-1315
26. Arabmotlagh M, Pilz M, Warzecha J, Rauschmann M: Changes of femoral periprosthetic bone mineral density 6 years after treatment with alendronate following total hip arthroplasty. 2008; J Orthop Res, Epub ahead of print
27. Colón-Emeric CS: Ten vs five years of bisphosphonate treatment for postmenopausal osteoporosis: enough of a good thing. JAMA 2006;27-296(24):2968-2969
28. Wilkinson JM, Eagleton AC, Stockley I et al: Effect of pamidronate on bone turnover and implant migration after total hip arthroplasty: a randomized trial. J Orthop Res 2005;23(1):1-8
29. Nixon M, Taylor G, Sheldon P, Iqbal SJ, Harper W: Does bone quality predict loosening of cemented total hip replacements? J Bone Joint Surg Br 2007;89(10):1303-1308
30. Gruen TA, McNeice GM, Amstutz HC: "Modes of failure" of cemented stem-type femoral components: a radiographic analysis of loosening. Clin Orthop Relat Res 1979;141:17-27